Cataract & LASIK Drops | OSRX Pharmaceuticals

Cataract & LASIK Drops

Post-op drop care for cataract and LASIK patients can be challenging and expensive. Our OMNI formulations improve the patient experience by compounding multiple medications into a single bottle to streamline dosing. This simplicity reduces barriers to use, promotes easy adherence and spares your patients from having to purchase 2-3 separate medications. OMNI formulations are water-soluble, gentle on the cornea and ship to your practice or patients free of charge.

How to Prescribe: First-time prescribers must submit a new account form. Once received, we will promptly contact you to discuss customized pricing, ordering, prescribing options as well as answer any remaining questions you may have.

Questions? Check out our FAQ.

Prednisolone Phosphate 1%
Moxifloxacin 0.5%
Bromfenac 0.075%
Sterile Ophthalmic Solution

Potential Contraindications

5 & 8 mL

Prednisolone Phosphate 1%
Moxifloxacin 0.5%
Sterile Ophthalmic Solution

Potential Contraindications

5 mL

Moxifloxacin 0.5%
Bromfenac 0.075%
Sterile Ophthalmic Solution

Potential Contraindications

5 mL

Prednisolone Phosphate 1%
Bromfenac 0.075%
Sterile Ophthalmic Solution

Potential Contraindications

4 mL

Prednisolone Phosphate 1%
Gatifloxacin 0.5%
Ketorolac Tromethamine 0.5%
Sterile Ophthalmic Solution

Potential Contraindications

4 mL & 7 mL

Prednisolone Phosphate 1%
Ketorolac Tromethamine 0.5%
Sterile Ophthalmic Solution

Potential Contraindications

4 mL

Tropicamide 1%
Phenylephrine HCl 2.5%
Sterile Ophthalmic Solution

Potential Contraindications

2 mL

Brimonidine Tartrate 0.2%
Dorzolamide 2%
Sterile Ophthalmic Solution

Potential Contraindications

2 mL

In a prospective multicenter trial, the combination of prednisolone phosphate 1% and gatifloxacin 0.5% was shown to be safe and therapeutically equivalent to conventional multiple medication therapy in the context of laser-assisted in-situ keratomileusis (LASIK). View the study here.

(Above) Drs. Nicole Fram, MD, and Elizabeth Yeu, MD, discussed why they credit compounded drops with streamlining their practice efficiencies and simplifying post-op cataract care on a recent episode of ASCRS Ophthalmology Quicksand Chronicles Podcast.

“Having used the (OMNI) compounded postoperative cataract surgery drops in over 5,000 patients, I can confidently say this has improved compliance, streamlined standardization and provided top notch safety in my cataract surgery post-op patients.”

- ELIZABETH YEU, MD, VIRGINIA EYE CONSULTANTS

“We’ve worked with multiple compounding pharmacies in our quest to make drop therapy more convenient, cost effective and compliant. OSRX has delivered where no others were able – providing high-quality, user-friendly and affordable compounded medications with unparalleled customer service.”
- PAUL MANN, MD & LUKE BARKER, MD, MANN EYE INSTITUTE AND LASER CENTER

“From a patient satisfaction standpoint, I can tell you without hesitation that patients are much happier with these products and our new level of service.”4
- JONATHAN D. SOLOMON, MD

“OSRX has been a pleasure to work with. We’ve been extremely happy with their compounded OMNI drops and use them exclusively for cataract surgery, LASIK and other procedures. Their bottles are easier to use than other pharmacy’s products, cost is minimal, and their customer service is second to none.”
- DAVID TREMBLAY, MD, MANN EYE INSTITUTE AND LASER CENTER

“From the very beginning of our relationship with OSRX, their team has provided top-notch customer service to our staff and patients. Their products are affordable for our patients and provide them with an easy, all-in-one system to use for their pre/post-operative treatment. In addition, their continued support and follow through is exceptional.”
- ANGIE RIDGE, DIRECTOR OF SURGERY COUNSELING, JOHN-KENYON EYE CENTERS

“… patients in my practice overwhelmingly preferred the convenience and decreased cost of a single drop.”³
- NICOLE FRAM, MD

“It is very convenient that patients have to only use one bottle of medications for surgery. It has eliminated any confusion on the patient's end and decreased chair time during post-op evaluations. I am very pleased with the compounded eye drops that we order through OSRX."
- MICHAEL ROM, MD, INSIGHT EYE CENTER

^3,4: MillennialEYE, 2017 Innovations: "A New Approach to Compounded Ophthalmic Therapies"

Professional Disclosure: Drs. Yeu, Fram, Mann and Solomon are on the Medical Advisory Board of Ocular Science^® (an affiliate of OSRX) and have a financial interest in the company.

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded medications are generally not reviewed by the FDA for safety or efficacy. OSRX does not compound copies of commercially available products. References available upon request.

Click here to view potential contraindications.

Schedule A Call